Vivani Medical, Inc.

NASDAQ:VANI

Medical - Devices

Healthcare
$1.05 +1.30%

+$0.02 today

Market cap
$94.71M
Beta
3.29
P/E (TTM)
-3.5
EPS (TTM)
-$0.33
52W Low $0.92High $1.92

Volume 0.18M

Average 0.24M

VANI Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

Vivani Medical, Inc.NASDAQ: VANI

Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Financing cash flow turns positive

Q1 FY2026 financing cash flow was $9.71M, compared with -$170K a year earlier. Trailing-twelve-month financing cash flow was $33.16M. Over 3 fiscal years it compounded at -28.4% a year.

Context

  • Financing cash flow increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly financing cash flow holds near $9.71M or moves back toward the trailing-twelve-month quarterly average of $8.29M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$9.71M-52.8% QoQ
Last fiscal yearDec 2025
$23.27M+22.1% YoY
LTMMar 2026
$33.16M+538.4% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5814.1%——
1 year+22.1%——
3-year CAGR-28.4%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
23.27M USD
Year-over-year change
+22.1%
4-year CAGR
+19.0%

Financing Cash Flow vs competitors

How VANI compares with its peers on the latest reported figures

  • Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +538.4% is the highest of 7, against a peer median of +65.5%.
  • Over three fiscal years its annual growth of -28.4% compares with a peer median of +171.2%.
VANI Competitors
Financing Cash Flow for VANI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IMAImageneBio IncLTM Mar 2026$132.22M USD—+398.3%—
MBOTMicrobot Medical Inc.LTM Mar 2026$58.43M USD+75.2%+171.2%55651.4%
HYPRHyperfine, Inc.LTM Mar 2026$36.41M USD+456.2%+1477.9%237.5%
VANIVivani Medical, Inc.LTM Mar 2026$33.16M USD+538.4%-28.4%—
CRDLCardiol Therapeutics Inc.LTM Mar 2026CA$29.19M CAD+55.7%——
RCELAVITA Medical, Inc.LTM Mar 2026$20.67M USD+538.0%+155.1%28.6%
ORMPOramed Pharmaceuticals Inc.LTM Mar 2026$15.14M USD-54.2%——
FONRFONAR CorporationLTM Mar 2026$4.61M USD-43.5%+8.4%4.4%
Peer median (excluding VANI) —+65.5%+171.2%133.0%

Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(12.77M)(13.89M)(25.65M)(23.49M)(26.61M)
Depreciation & Amortization345K381K357K400K424K
Deferred Income Tax00000
Stock-Based Compensation1.67M1.3M1.86M1.61M1.48M
Change in Working Capital436K338K(1.29M)354K229K
Accounts Receivables0000(401K)
Inventory00000
Accounts Payables13K(1.94M)(602K)248K(222K)
Other Working Capital423K2.28M(691K)106K852K
Other Non-Cash Items(627K)(6.91M)1.03M336K152K
Operating Cash Flow(10.95M)(18.79M)(23.7M)(20.79M)(24.32M)
Capital Expenditures(572K)(338K)(887K)(556K)(1.17M)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(572K)(338K)(887K)(556K)(1.17M)
Debt Repayment08M019.05M11K
Common Stock Issued11.62M16K133K18.82M23.29M
Common Stock Repurchased0000(28K)
Dividends Paid00000
Other Financing Activities055.37M0(18.82M)0
Financing Cash Flow11.62M63.39M133K19.05M23.27M
Effect of Forex Changes(1.1M)(1K)3K(14K)99K
Net Change in Cash97K44.26M(24.45M)(2.3M)(2.12M)
Free Cash Flow(11.52M)(19.13M)(24.59M)(21.34M)(25.49M)

Vivani Medical, Inc.

NASDAQ:VANI

Intrinsic Alpha fair value

Locked

Current Price

$1.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.